BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease

Posted: December 21, 2021 at 8:34 pm   /   by   /   comments (0)